Horne Rob, Parham Rhian, Driscoll Richard, Robinson Andrew
Centre for Behavioural Medicine, Department of Practice & Policy, School of Pharmacy, University of London, London, UK.
Inflamm Bowel Dis. 2009 Jun;15(6):837-44. doi: 10.1002/ibd.20846.
Nonadherence has been reported in over 40% of patients taking maintenance therapies (MT) for inflammatory bowel disease (IBD). Studies in other illness groups have shown that nonadherence is related to negative attitudes to treatment. The aim of this study was to assess patients' attitudes to MT for IBD (beliefs about personal need for MT and potential adverse effects) and to identify whether such beliefs are associated with adherence to MT.
A cross-sectional survey was conducted in which 1871 members of the National Association for Colitis and Crohn's Disease (NACC) completed validated questionnaires assessing beliefs about MT and adherence to MT.
Low adherence to MT was reported by 29% of participants and was associated with doubts about personal need for MT (odds ratio [OR] = 0.56; 95% confidence interval [CI]: 0.48-0.64; P < 0.001) and concerns about potential adverse effects (OR = 1.66; 95% CI: 1.42-1.94; P < 0.001). Attitudinal analysis showed that while almost half (48%) of the participants were "accepting" of MT (high necessity, low concerns), a large proportion of the sample (42%) were "ambivalent" about MT (high necessity, high concerns), 6% were "sceptical" (low necessity, high concerns) and 4% were "indifferent" (low necessity, low concerns). Compared to those who were "accepting" of MT, participants in all 3 other attitudinal groups were significantly more likely to be nonadherent.
The way in which patients judge their personal need for MT relative to their concerns about MT can be a significant barrier to adherence. Interventions to facilitate optimal adherence to MT for IBD should address such perceptual barriers.
据报道,超过40%接受炎症性肠病(IBD)维持治疗(MT)的患者存在治疗不依从情况。其他疾病组的研究表明,治疗不依从与对治疗的消极态度有关。本研究的目的是评估患者对IBD的MT的态度(对个人MT需求的信念和潜在不良反应),并确定这些信念是否与MT的依从性相关。
进行了一项横断面调查,1871名全国结肠炎和克罗恩病协会(NACC)成员完成了经过验证的问卷,评估对MT的信念和MT的依从性。
29%的参与者报告MT依从性低,这与对个人MT需求的怀疑(比值比[OR]=0.56;95%置信区间[CI]:0.48-0.64;P<0.001)和对潜在不良反应的担忧(OR=1.66;95%CI:1.42-1.94;P<0.001)有关。态度分析表明,虽然近一半(48%)的参与者“接受”MT(高必要性,低担忧),但很大一部分样本(42%)对MT“矛盾”(高必要性,高担忧),6%“怀疑”(低必要性,高担忧),4%“漠不关心”(低必要性,低担忧)。与“接受”MT的参与者相比,其他所有态度组的参与者更有可能不依从。
患者判断其个人对MT的需求相对于对MT的担忧的方式可能是依从性的一个重大障碍。促进IBD患者最佳依从MT的干预措施应解决此类认知障碍。